The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-488-2013·Announced 2013-06-05

Nora Apothecary Recalls Hydroxyprogesterone Injections Due to Sterility Concerns

Nora Apothecary and Alternative Therapies, Inc. is recalling Hydroxyprogesterone Inj 250mg/ml MDV, 5 ml Intramuscular due to FDA inspection findings regarding quality control and lack of assurance of sterility.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class II. According to the rubric, FDA Class II recalls are typically scored as 4 (Severe), particularly when involving significant risks such as sterility assurance failures in injectable drugs.

Plain-English summary

Nora Apothecary and Alternative Therapies, Inc. is recalling Hydroxyprogesterone Inj 250mg/ml MDV, 5 ml Intramuscular, 30 day expiration. The recall was initiated following FDA inspection findings that raised concerns regarding the quality control processes used to manufacture the product.

The specific hazard identified is a lack of assurance of sterility. The recall covers all products within their expiration date, including those dated 90 days prior to April 19, 2013 (January 2013 to April 19, 2013). The distribution pattern for these products is nationwide.

Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on how to return or dispose of the medication.

The recalled product

Product
Hydroxyprogesterone Inj 250mg/ml MDV, 5 ml Intramuscular, 30 day expiration,
Manufacturer
Nora Apothecary and Alternative Therapies, Inc.
Category
Drug — Injectable
Hazard
Affected units
5

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • 2013 (Jan. 2013 to April 19
  • 2013).

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 43 recalled by Nora Apothecary and Alternative Therapies, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 43 products in this recall →

Related recalls

Same manufacturer · Nora Apothecary and Alternative Therapies, Inc.

See all →

Same hazard · sterility

See all →

Similar recalls